NorthWest Biotherapeutics Inc (NWBO)

[VikingInvest]

One positive in this short dominated SP downturn is that a non equity partnership for an indication or several indications with an upfront payment and milestone payments along the way to commercialization and a profit sharing post-commercialization is completely independent on the current SP, and solely dependent on potential revenue for the partnership in the indications. I still think that something along these lines is still a possibility. If that is the case, I think they are waiting for the MIA and possibly the Flaskworks patent. They do need to have confirmation that NWBO can produce the goods. This set-up also is beneficial for the partner as their initial cost is limited and the total cost will only be paid after they are certain of the financial benefit to them.